Memorial Sloan-Kettering, N.Y., to sell $400 million taxable bonds

By Sheri Kasprzak

New York, Nov. 29 - The Memorial Sloan-Kettering Cancer Center in New York is set to price $400 million of series 2011A taxable revenue bonds, according to a preliminary official statement. Pricing is expected Thursday.

The bonds (Aa2/AA-/AA) will be sold on a negotiated basis with Goldman Sachs & Co. as the lead manager. The co-managers are J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC.

The maturity dates have not been set, but it is expected the bonds will be sold in two tranches.

Proceeds will be used to fund capital projects for the cancer center.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.